A Study to Evaluate Touchless Monitoring Device for COVID-19 Patients

Overview

About this study

  1. The purpose of this pilot study is to determine if a touchless monitoring platform may provide respiratory and other clinical data on subjects with COVID-19. 

Eventually, this type of data may assist in the care of COVID-19 patients, reduce provider time in the hospital room, and provide a platform to monitor patient recovery at home.

 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Consented adult (18+) male and female subjects; for hospitalized patients, consent may be obtained from LAR.
  • Have a confirmed diagnosis of COVID-19.
  • For outpatient home monitoring only (for subjects who were not admitted to the hospital): subjects must also be in a high-risk category (with history of one or more of the following):
    • Asthma;
    • Age greater than or equal to 65;
    • Diabetes;
    • Current smoker;
    • Chronic lung disease (asthma, cystic fibrosis, COPD, emphysema, IPF, bronchiectasis);
    • Active chemotherapy;
    • Bone marrow or organ transplant;
    • Other immunocompromising condition;
    • End stage renal disease;
    • Chronic liver disease.

Exclusion Criteria: 

  • Subjects who are pregnant or may be pregnant.
  • Pediatric patients (< 18 years of age).
  • Subjects unable or unwilling to deploy the Emerald device for remote monitoring.
  • Hospitalized subjects whose care team does not wish to have the Emerald device deployed within the hospital room for any reason.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Melissa Lipford, M.D.

Contact us for the latest status

Contact information:

Melissa Lipford M.D.

Lipford.Melissa@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20508804

Mayo Clinic Footer